226 related articles for article (PubMed ID: 28333259)
21. Do clinical features allow for accurate prediction of fungal pathogenesis in bloodstream infections? Potential implications of the increasing prevalence of non-albicans candidemia.
Shorr AF; Lazarus DR; Sherner JH; Jackson WL; Morrel M; Fraser VJ; Kollef MH
Crit Care Med; 2007 Apr; 35(4):1077-83. PubMed ID: 17312565
[TBL] [Abstract][Full Text] [Related]
22. Recent experience with fungaemia: change in species distribution and azole resistance.
Chakrabarti A; Chatterjee SS; Rao KL; Zameer MM; Shivaprakash MR; Singhi S; Singh R; Varma SC
Scand J Infect Dis; 2009; 41(4):275-84. PubMed ID: 19229762
[TBL] [Abstract][Full Text] [Related]
23. Antifungal susceptibilities of Candida glabrata species complex, Candida krusei, Candida parapsilosis species complex and Candida tropicalis causing invasive candidiasis in China: 3 year national surveillance.
Xiao M; Fan X; Chen SC; Wang H; Sun ZY; Liao K; Chen SL; Yan Y; Kang M; Hu ZD; Chu YZ; Hu TS; Ni YX; Zou GL; Kong F; Xu YC
J Antimicrob Chemother; 2015 Mar; 70(3):802-10. PubMed ID: 25473027
[TBL] [Abstract][Full Text] [Related]
24. High incidence of Candida parapsilosis candidaemia in non-neutropenic critically ill patients: epidemiology and antifungal susceptibility.
Dizbay M; Fidan I; Kalkanci A; Sari N; Yalcin B; Kustimur S; Arman D
Scand J Infect Dis; 2010; 42(2):114-20. PubMed ID: 19883150
[TBL] [Abstract][Full Text] [Related]
25. Risk factors for fluconazole-resistant candidemia.
Garnacho-Montero J; Díaz-Martín A; García-Cabrera E; Ruiz Pérez de Pipaón M; Hernández-Caballero C; Aznar-Martín J; Cisneros JM; Ortiz-Leyba C
Antimicrob Agents Chemother; 2010 Aug; 54(8):3149-54. PubMed ID: 20498325
[TBL] [Abstract][Full Text] [Related]
26. A first Portuguese epidemiological survey of fungaemia in a university hospital.
Costa-de-Oliveira S; Pina-Vaz C; Mendonça D; Gonçalves Rodrigues A
Eur J Clin Microbiol Infect Dis; 2008 May; 27(5):365-74. PubMed ID: 18204871
[TBL] [Abstract][Full Text] [Related]
27. Variation in Candida spp. distribution and antifungal resistance rates among bloodstream infection isolates by patient age: report from the SENTRY Antimicrobial Surveillance Program (2008-2009).
Pfaller MA; Castanheira M; Messer SA; Moet GJ; Jones RN
Diagn Microbiol Infect Dis; 2010 Nov; 68(3):278-83. PubMed ID: 20846808
[TBL] [Abstract][Full Text] [Related]
28. [Comparison of broth microdilution and E-test methods for the antifungal susceptibility testing of Candida spp. strains isolated from blood cultures].
Ozcan SK; Mutlu B; Dündar D; Willke A
Mikrobiyol Bul; 2010 Apr; 44(2):263-71. PubMed ID: 20549961
[TBL] [Abstract][Full Text] [Related]
29. Aetiology and antifungal susceptibility of yeast bloodstream infections in a Hungarian university hospital between 1996 and 2000.
Dóczi I; Dósa E; Hajdú E; Nagy E
J Med Microbiol; 2002 Aug; 51(8):677-681. PubMed ID: 12171299
[TBL] [Abstract][Full Text] [Related]
30. Clinical characteristics of Candida tropicalis fungaemia with reduced triazole susceptibility in Taiwan: a multicentre study.
Liu WL; Huang YT; Hsieh MH; Hii IM; Lee YL; Ho MW; Liu CE; Chen YH; Wang FD
Int J Antimicrob Agents; 2019 Feb; 53(2):185-189. PubMed ID: 30722962
[TBL] [Abstract][Full Text] [Related]
31. Candida glabrata fungaemia in a tertiary centre in Taiwan: antifungal susceptibility and outcomes.
Ruan SY; Huang YT; Chu CC; Yu CJ; Hsueh PR
Int J Antimicrob Agents; 2009 Sep; 34(3):236-9. PubMed ID: 19361960
[TBL] [Abstract][Full Text] [Related]
32. Epidemiological changes with potential implication for antifungal prescription recommendations for fungaemia: data from a nationwide fungaemia surveillance programme.
Arendrup MC; Dzajic E; Jensen RH; Johansen HK; Kjaeldgaard P; Knudsen JD; Kristensen L; Leitz C; Lemming LE; Nielsen L; Olesen B; Rosenvinge FS; Røder BL; Schønheyder HC
Clin Microbiol Infect; 2013 Aug; 19(8):E343-53. PubMed ID: 23607326
[TBL] [Abstract][Full Text] [Related]
33. Mixed fungaemia: an 18-year report from a tertiary-care university hospital and a systematic review.
Gülmez D; Alp S; Gursoy G; Ayaz CM; Dogan O; Arikan-Akdagli S; Akova M
Clin Microbiol Infect; 2020 Jul; 26(7):833-841. PubMed ID: 32246995
[TBL] [Abstract][Full Text] [Related]
34. In vitro susceptibilities of bloodstream isolates of Candida spp.: results from a multicenter active surveillance program in Andalusia.
Flórez C; Martín-Mazuelos E; Ruiz M; Cisneros JM; Herrero M; García MV; Márquez M; Porras J; Martín P; Gamero C; Castón JJ;
Enferm Infecc Microbiol Clin; 2009 Nov; 27(9):518-22. PubMed ID: 19477048
[TBL] [Abstract][Full Text] [Related]
35. Seminational surveillance of fungemia in Denmark: notably high rates of fungemia and numbers of isolates with reduced azole susceptibility.
Arendrup MC; Fuursted K; Gahrn-Hansen B; Jensen IM; Knudsen JD; Lundgren B; Schønheyder HC; Tvede M
J Clin Microbiol; 2005 Sep; 43(9):4434-40. PubMed ID: 16145088
[TBL] [Abstract][Full Text] [Related]
36. Nosocomial candidaemias due to species other than Candida albicans in cancer patients. Aetiology, risk factors, and outcome of 45 episodes within 10 years in a single cancer institution.
Krcmery V; Mrazova M; Kunova A; Grey E; Mardiak J; Jurga L; Sabo A; Sufliarsky J; Sevcikova L; Sorkovska D; West D; Trupl J; Novotny J; Mateicka F
Support Care Cancer; 1999 Nov; 7(6):428-31. PubMed ID: 10541986
[TBL] [Abstract][Full Text] [Related]
37. Candida spp. in vitro susceptibility profile to four antifungal agents. Resistance surveillance study in Venezuelan strains.
Panizo MM; Reviákina V; Dolande M; Selgrad S
Med Mycol; 2009 Mar; 47(2):137-43. PubMed ID: 18651308
[TBL] [Abstract][Full Text] [Related]
38. [Epidemiology of candidemia: results of a one month French hospitals-based surveillance study in 2004].
Eloy O; Blanc V; Pina P; Gaudart A; Bressolle ML; Plainvert C; Decousser JW; Pangon B; Allouch PY;
Pathol Biol (Paris); 2006; 54(8-9):523-30. PubMed ID: 17029814
[TBL] [Abstract][Full Text] [Related]
39. Species distribution and antifungal susceptibility of Candida bloodstream isolates in a tertiary medical center in Israel.
Samra Z; Yardeni M; Peled N; Bishara J
Eur J Clin Microbiol Infect Dis; 2005 Sep; 24(9):592-5. PubMed ID: 16172856
[TBL] [Abstract][Full Text] [Related]
40. Outcome in critically ill patients with candidal fungaemia: Candida albicans vs. Candida glabrata.
Blot S; Vandewoude K; Hoste E; Poelaert J; Colardyn F
J Hosp Infect; 2001 Apr; 47(4):308-13. PubMed ID: 11289775
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]